Design, synthesis and evaluation of galanthamine derivatives as acetylcholinesterase inhibitors
- 28 February 2009
- journal article
- Published by Elsevier BV in European Journal of Medicinal Chemistry
- Vol. 44 (2), 772-784
- https://doi.org/10.1016/j.ejmech.2008.04.018
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (30572239)
- Ministry of Education of the People's Republic of China (20050335045)
This publication has 30 references indexed in Scilit:
- Progress in acetylcholinesterase inhibitors for Alzheimer’s diseaseExpert Opinion on Therapeutic Patents, 2006
- Review of the acetylcholinesterase inhibitor galanthamineExpert Opinion on Investigational Drugs, 2000
- Cholinergic therapies in Alzheimer's diseaseDrugs of the Future, 1999
- Donepezil Use in Alzheimer DiseaseAnnals of Pharmacotherapy, 1998
- RivastigmineDrugs & Aging, 1998
- Cholinesterase Inhibitors in the Treatment of Alzheimer??s DiseaseDrug Safety, 1998
- Cholinergic activity and amyloid precursor protein metabolismBrain Research Reviews, 1997
- DonepezilDrugs & Aging, 1997
- TacrineThe Lancet, 1995
- Alzheimer's disease: therapeutic strategies for the 1990sNeurobiology of Aging, 1994